Incidence and prevalence of multiple endocrine neoplasia 2A in Denmark 1901-2014: a nationwide study

scientific article published on 12 October 2018

Incidence and prevalence of multiple endocrine neoplasia 2A in Denmark 1901-2014: a nationwide study is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.2147/CLEP.S174606
P932PMC publication ID6190626
P698PubMed publication ID30349395

P50authorFinn Cilius NielsenQ30344758
Christian GodballeQ44009330
Sören MöllerQ55030481
Jes Sloth MathiesenQ56994246
Ulla Feldt-RasmussenQ57422236
Kirstine StochholmQ58418397
P2093author name stringMaria Rossing
Kim Brixen
Peter Vestergaard
Anja Lisbeth Frederiksen
Jens Bentzen
Mette Gaustadnes
Sten Schytte
Åse Krogh Rasmussen
Per Løgstrup Poulsen
Jens Peter Kroustrup
Christoffer Holst Hahn
Henrik Baymler Pedersen
P2860cites workChoroidal metastases in multiple endocrine neoplasia type 2BQ79629536
RET proto-oncogene in Sardinia: V804M is the most frequent mutation and may be associated with FMTC/MEN-2A phenotypeQ79814534
Novel Somatic RET Mutation Questioning the Causality of the RET I852M Germline Sequence Variant in Multiple Endocrine Neoplasia 2AQ88230681
Molecular epidemiology of multiple endocrine neoplasia 2: implications for RET screening in the new milleniumQ30317941
Existing data sources for clinical epidemiology: Danish registries for studies of medical genetic diseasesQ30662801
Revised American Thyroid Association guidelines for the management of medullary thyroid carcinomaQ34468665
Epidemiology, clinical features, and genetics of multiple endocrine neoplasia type 2B in a complete populationQ34641074
Comprehensive assessment of the disputed RET Y791F variant shows no association with medullary thyroid carcinoma susceptibilityQ34906650
Prevalence, incidence, and age at diagnosis in Marfan SyndromeQ36344156
Medullary thyroid cancer: RET testing of an archival materialQ38419660
Risk Profile of the RET A883F Germline Mutation: An International Collaborative StudyQ38890175
Evidence for the founder effect of RET533 as the common Greek and Brazilian ancestor spreading multiple endocrine neoplasia 2A.Q38991268
Medullary thyroid carcinoma and calcitoninQ39357847
A Nationwide Study of Multiple Endocrine Neoplasia Type 2A in Norway: Predictive and Prognostic Factors for the Clinical Course of Medullary Thyroid CarcinomaQ39613599
Distribution of RET Mutations in Multiple Endocrine Neoplasia 2 in Denmark 1994-2014: A Nationwide StudyQ40491580
Primary diagnosis of multiple pheochromocytomas in the brother of a MEN-2 patient by simultaneous MIBG scintigraphy and low-dose computed tomographyQ40603320
Calcitonin and PDN-21 as tumour markers in MEN-2 family screening for medullary thyroid carcinomaQ42453110
Calcitonin gene-related peptide and calcitonin as tumour markers in MEN 2 family screeningQ42495031
Medullary thyroid cancer in Norway. A 30-year experienceQ42519787
Medullary thyroid cancer--screeningQ43662211
Medullary carcinoma of the thyroid gland. A review and report of 4 casesQ44124502
The Danish Cancer RegistryQ45848855
Can measurement of basal calcitonin replace the pentagastrin test?Q46305880
Founder Effect of the RETC611Y Mutation in Multiple Endocrine Neoplasia 2A in Denmark: A Nationwide StudyQ47819138
Multiple endocrine neoplasia type 2 RET protooncogene database: repository of MEN2-associated RET sequence variation and reference for genotype/phenotype correlationsQ48675067
Multiple endocrine neoplasia 2 in Cyprus: evidence for a founder effectQ49356194
Screening for hereditary medullary cancer in DenmarkQ50553109
The Danish National Patient Register.Q50554196
The Danish Pathology Register.Q50554236
Incidence and prevalence of multiple endocrine neoplasia 2B in Denmark: a nationwide study.Q50575214
[Medullary thyroid carcinoma in a 10-month-old child with multiple endocrine neoplasia 2B].Q54382356
Aggressive medullary thyroid carcinoma in a ten-year-old patient with multiple endocrine neoplasia 2B due to the A883F mutation.Q55071074
Incidence and prevalence of sporadic and hereditary MTC in Denmark 1960-2014: a nationwide study.Q55377929
Completeness and validity in a national clinical thyroid cancer database: DATHYRCAQ60723964
Is thyroidectomy necessary in RET mutations carriers of the familial medullary thyroid carcinoma syndrome?Q61757267
[Multiple endocrine neoplasia type 2a and 2b]Q64050685
Calcitonin gene-related peptide and calcitonin in medullary thyroid carcinomaQ68187805
Altered vitamin D metabolism and bone remodelling in patients with medullary thyroid carcinoma and hypercalcitoninemiaQ70459036
Familial medullary thyroid carcinoma in multiple endocrine neoplasia (MEN) IIa: diagnosis and problems in treatmentQ72536823
[Thyroid cancer in the county of North Jutland. Diagnosis, treatment and prognosis]Q72794451
Calcitonin gene-related peptide in medullary thyroid carcinomas: characterization of molecular forms including the amidated C-terminusQ72867393
Rapid MEN 2A gene carrier identification using primer-specific PCR amplificationQ73484361
P275copyright licenseCreative Commons Attribution-NonCommercial 3.0 UnportedQ18810331
P6216copyright statuscopyrightedQ50423863
P407language of work or nameEnglishQ1860
P921main subjectDenmarkQ35
multiple endocrine neoplasiaQ1553018
P304page(s)1479-1487
P577publication date2018-10-12
P1433published inClinical EpidemiologyQ5133758
P1476titleIncidence and prevalence of multiple endocrine neoplasia 2A in Denmark 1901-2014: a nationwide study
P478volume10